CEO Executive AssistantGetting started with a virtual EA in pharmaceutical and biotech is a specific, actionable process that takes most pharmaceutical CEOs from initial decision to active EA support in two to four weeks. The path is not complicated, but it is sequential and the steps matter. Skipping preparation or rushing through onboarding consistently produces disappointing results.
This guide gives you the practical sequence from decision to first productive week.
The Mindset Shift: From Doing to Delegating
Before getting started with a virtual EA, the most important preparation is a mindset shift that many pharmaceutical CEOs find counterintuitive.
The instinct for a pharmaceutical CEO, developed over years of operating in a high-accountability environment where everything matters, is to maintain direct control over every communication and decision. That instinct is appropriate for clinical and regulatory strategy. It is actively counterproductive when applied to scheduling, travel booking, and email management.
Getting started with EA support requires giving up direct control of functions you have managed yourself and trusting a capable EA to handle them with appropriate oversight rather than close supervision. This shift is what actually produces time recovery. Without it, you create a situation where you check every email your EA processes and review every calendar change they make, which eliminates the leverage entirely.
Practice deliberate delegation from day one. Review your EA’s output less frequently over the first 30 days, not more frequently. Provide feedback when needed, but move toward trusting their judgment rather than verifying every action.
Step 1: Define What You Are Getting Started With
The most common reason pharmaceutical CEOs get started poorly is that they are vague about what they actually want. “Someone to help with my schedule and email” is a starting direction, not a scope definition.
Before you contact a single service, spend one hour writing a requirements document that answers these questions:
- What are the five to eight task categories I need support with?
- How many hours per week does each task category currently require from me?
- What pharmaceutical-specific context does my EA need (regulatory calendar, investor relations, clinical confidentiality)?
- What communication quality standard does my EA need to meet for external-facing work?
- What are my absolute non-negotiables (availability hours, confidentiality terms, response time)?
- What is my monthly budget?
This document becomes the foundation of every conversation you have with potential services.
Step 2: Select One Service and Commit
Pharmaceutical CEOs who evaluate six services simultaneously often spend more time in evaluation than they would have spent onboarding a good EA. The marginal improvement in decision quality from evaluating five services versus two is small. The time cost is significant.
Evaluate two to three services thoroughly and commit to one. The first service you engage is unlikely to be your last EA service ever. If the relationship does not work, you change services. The cost of a wrong choice is low when you have not locked into a long-term contract.
For a comparison of services well-suited to pharmaceutical executives, see remote EA for pharma. For a full overview of the best virtual EA options for pharma CEOs, best virtual EA for pharma covers the full market.
Step 3: Complete the Sign-Up Process Promptly
Once you have selected a service, complete the sign-up process within 48 hours. The most common delay in getting EA support is decision-to-action lag: a CEO who decides they want EA support but then takes two months to complete the sign-up process because they are busy.
Block three hours in your next two business days to: complete the service intake form, review and sign the service agreement, execute the NDA, and provision calendar access for your new EA. This block of time is the gateway to the leverage you are seeking.
Step 4: Build Your Onboarding Brief Before Day One
Before your EA’s first day, prepare a structured onboarding brief. This document is the most important thing you give your EA:
Section 1: Company Overview - What your pharmaceutical company does, your development stage, your pipeline, and the most important milestones in the next 12 months.
Section 2: Regulatory Calendar - Every significant FDA milestone, meeting type, or submission deadline in the next 12 months with context on what each requires from a calendar preparation perspective.
Section 3: Key Stakeholders - Your top 10 to 15 external stakeholders with context on each: who they are, their relationship to you, communication preferences, and any relevant sensitivities.
Section 4: Communication Standards - Three to five examples of excellent communications from your files with notes explaining why they are effective.
Section 5: Scheduling Preferences - Specific preferences: protected days, time block requirements, buffer time for specific meeting types, travel booking guidelines.
Section 6: Information Handling Protocols - What information your EA will access, what requires your authorization before sharing, and how to handle uncertainty.
Step 5: Run a Productive First Week
Your EA’s first week sets the tone for the relationship. Do not make it a gentle introduction with only trivial tasks. Give your EA work that is representative of what they will handle regularly and evaluate the output carefully.
Schedule a 30-minute briefing call at the start of day one. Walk through the onboarding brief verbally in addition to sharing the document. This creates a human connection and gives your EA a chance to ask clarifying questions.
Assign at least five to seven real tasks in week one that span different categories. Evaluate each one and provide specific, prompt feedback. This feedback loop is what accelerates ramp-up.
End week one with a brief check-in to discuss what went well and what needs adjustment.
What the First 90 Days Look Like
Weeks 1 to 2: Calibration. Your EA is learning your systems, preferences, and pharmaceutical context. Expect some errors and course correction. This is normal.
Weeks 3 to 6: Pattern establishment. Your EA develops rhythm with your recurring tasks and begins handling them more independently. Your management time decreases.
Weeks 7 to 12: Operational depth. Your EA begins anticipating needs, flagging issues proactively, and managing your calendar and communications with increasing independence. This is where the leverage becomes clearly visible.
Research from McKinsey confirms that pharmaceutical executives who invest in the first 90 days of an EA relationship through structured onboarding, regular feedback, and progressive delegation achieve full relationship value significantly faster than those who adopt a wait-and-see approach. The 90-day investment determines the quality of the relationship for years.
Conclusion
Getting started with a virtual EA in pharmaceutical and biotech requires a mindset shift from doing to delegating, a clear requirements document, service selection and sign-up within two to four weeks of decision, a structured onboarding brief prepared before day one, and a productive first week that establishes norms through real work and direct feedback. Follow this sequence and you will have a well-functioning pharmaceutical EA relationship within 90 days. The time you recover from that point forward compounds continuously as your EA deepens their context and operates with increasing independence.
Related Reading
For further context, explore Get Started With a Virtual EA in Automotive and Get Started With a Virtual EA in Construction & Architecture.